Allogene Therapeutics, Inc. Common Stock (ALLO) News
Latest headlines that mention ALLO, newest first · each headline opens the original publisher
- Last price
- $1.21
- Day change
- -3.20%
- Next earnings
- 2026-11-05
ALLO headlines
latest coverageCema-cel hit 58.3% MRD negativity in ALPHA3 with zero treatment hospitalizations.
Image source: The Motley Fool. Wednesday, May 13, 2026 at 5 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
ALLO news alerts
Get an alert by email or push when a new headline mentions ALLO.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.